rs3760469
|
|
1.000 |
0.080 |
17 |
51153191 |
upstream gene variant
|
T/G
|
snv
|
|
0.55
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2012 |
2012 |
rs2439302
|
|
0.776 |
0.200 |
8 |
32574851 |
intron variant
|
G/C
|
snv
|
|
0.54
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2016 |
2016 |
rs2071559
|
|
0.667 |
0.680 |
4 |
55126199 |
upstream gene variant
|
A/G
|
snv
|
|
0.53
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs763110
|
|
0.653 |
0.560 |
1 |
172658358 |
upstream gene variant
|
C/T
|
snv
|
|
0.49
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2016 |
2016 |
rs931127
|
|
0.790 |
0.160 |
11 |
65637829 |
upstream gene variant
|
G/A
|
snv
|
|
0.49
|
Secondary malignant neoplasm of lymph node
|
0.010 |
< 0.001 |
1 |
2009 |
2009 |
rs57698689
|
|
1.000 |
0.080 |
12 |
25205729 |
3 prime UTR variant
|
TT/-;T
|
delins
|
|
0.48
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs9679162
|
|
0.882 |
0.120 |
2 |
31024648 |
intron variant
|
G/T
|
snv
|
|
0.48
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs135745
|
|
0.763 |
0.200 |
22 |
38287631 |
downstream gene variant
|
G/C
|
snv
|
|
0.48
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs11077
|
|
0.732 |
0.320 |
6 |
43523209 |
3 prime UTR variant
|
T/G
|
snv
|
|
0.47
|
Secondary malignant neoplasm of lymph node
|
0.010 |
< 0.001 |
1 |
2016 |
2016 |
rs4880
|
|
0.500 |
0.840 |
6 |
159692840 |
missense variant
|
A/G
|
snv
|
0.48
|
0.47
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2012 |
2012 |
rs2288947
|
|
0.827 |
0.160 |
19 |
5562104 |
3 prime UTR variant
|
G/A
|
snv
|
|
0.45
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs653765
|
|
0.763 |
0.240 |
15 |
58749813 |
upstream gene variant
|
T/C;G
|
snv
|
|
0.45
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2018 |
2018 |
rs944289
|
|
0.742 |
0.200 |
14 |
36180040 |
upstream gene variant
|
C/T
|
snv
|
|
0.45
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs2294008
|
|
0.672 |
0.320 |
8 |
142680513 |
5 prime UTR variant
|
C/T
|
snv
|
0.46
|
0.45
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2016 |
2016 |
rs2976392
|
|
0.724 |
0.240 |
8 |
142681514 |
3 prime UTR variant
|
G/A
|
snv
|
0.46
|
0.45
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2016 |
2016 |
rs2607775
|
|
0.807 |
0.160 |
3 |
14178595 |
5 prime UTR variant
|
C/G
|
snv
|
0.42
|
0.43
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs10877887
|
|
0.701 |
0.440 |
12 |
62603400 |
non coding transcript exon variant
|
T/C
|
snv
|
|
0.42
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs6024836
|
|
0.851 |
0.160 |
20 |
56369012 |
downstream gene variant
|
G/A
|
snv
|
|
0.42
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs13140012
|
|
0.827 |
0.320 |
4 |
186544404 |
intron variant
|
T/A
|
snv
|
|
0.41
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs1478604
|
|
0.807 |
0.240 |
15 |
39581120 |
5 prime UTR variant
|
T/C
|
snv
|
|
0.40
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2012 |
2012 |
rs10505477
|
|
0.658 |
0.400 |
8 |
127395198 |
intron variant
|
A/G
|
snv
|
|
0.40
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs2288496
|
|
0.925 |
0.120 |
14 |
81145770 |
3 prime UTR variant
|
T/C
|
snv
|
|
0.39
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs3917356
|
|
0.882 |
0.160 |
2 |
112834786 |
intron variant
|
C/T
|
snv
|
|
0.39
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2012 |
2012 |
rs34214448
|
|
0.851 |
0.120 |
17 |
51154651 |
intron variant
|
G/T
|
snv
|
|
0.39
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2012 |
2012 |
rs3760468
|
|
0.882 |
0.120 |
17 |
51153130 |
upstream gene variant
|
A/T
|
snv
|
|
0.39
|
Secondary malignant neoplasm of lymph node
|
0.010 |
1.000 |
1 |
2012 |
2012 |